Epplen JT - Search Results

1

NMDA receptor gene variations as modifiers in Huntington disease: a replication study.

Saft C, Epplen JT, Wieczorek S, Landwehrmeyer GB, Roos RA, de Yebenes JG, Dose M, Tabrizi SJ, Craufurd D; REGISTRY Investigators of the European Huntington's Disease Network; Arning L. Saft C, et al. Among authors: epplen jt. PLoS Curr. 2011 Oct 4;3:RRN1247. doi: 10.1371/currents.RRN1247. PLoS Curr. 2011. PMID: 21989477 Free PMC article.

2

Age at onset in Huntington's disease: replication study on the associations of ADORA2A, HAP1 and OGG1.

Taherzadeh-Fard E, Saft C, Wieczorek S, Epplen JT, Arning L. Taherzadeh-Fard E, et al. Among authors: epplen jt. Neurogenetics. 2010 Oct;11(4):435-9. doi: 10.1007/s10048-010-0248-3. Epub 2010 May 30. Neurogenetics. 2010. PMID: 20512606

3

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.

Arning L, Saft C, Wieczorek S, Andrich J, Kraus PH, Epplen JT. Arning L, et al. Among authors: epplen jt. Hum Genet. 2007 Sep;122(2):175-82. doi: 10.1007/s00439-007-0393-4. Epub 2007 Jun 14. Hum Genet. 2007. PMID: 17569088

4

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.

Mai M, Akkad AD, Wieczorek S, Saft C, Andrich J, Kraus PH, Epplen JT, Arning L. Mai M, et al. Among authors: epplen jt. BMC Med Genet. 2006 Nov 10;7:79. doi: 10.1186/1471-2350-7-79. BMC Med Genet. 2006. PMID: 17096834 Free PMC article.

5

PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease.

Taherzadeh-Fard E, Saft C, Akkad DA, Wieczorek S, Haghikia A, Chan A, Epplen JT, Arning L. Taherzadeh-Fard E, et al. Among authors: epplen jt. Mol Neurodegener. 2011 May 19;6(1):32. doi: 10.1186/1750-1326-6-32. Mol Neurodegener. 2011. PMID: 21595933 Free PMC article.

6

CNR1 variation is associated with the age at onset in Huntington disease.

Kloster E, Saft C, Epplen JT, Arning L. Kloster E, et al. Among authors: epplen jt. Eur J Med Genet. 2013 Aug;56(8):416-9. doi: 10.1016/j.ejmg.2013.05.007. Epub 2013 Jun 7. Eur J Med Genet. 2013. PMID: 23747361

7

Genetic modifiers in Huntington's disease: fiction or fact?

Arning L, Epplen JT. Arning L, et al. Among authors: epplen jt. Neurogenetics. 2013 Nov;14(3-4):171-2. doi: 10.1007/s10048-013-0365-x. Neurogenetics. 2013. PMID: 23754186 No abstract available.

8

Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R.

Kloster E, Saft C, Akkad DA, Epplen JT, Arning L. Kloster E, et al. Among authors: epplen jt. J Mol Med (Berl). 2014 Feb;92(2):177-84. doi: 10.1007/s00109-013-1092-3. J Mol Med (Berl). 2014. PMID: 24121255

9

Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.

Arning L, Jagiello P, Wieczorek S, Saft C, Andrich J, Epplen JT. Arning L, et al. Among authors: epplen jt. BMC Med Genet. 2004 Mar 24;5:7. doi: 10.1186/1471-2350-5-7. BMC Med Genet. 2004. PMID: 15040808 Free PMC article.

10

NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.

Arning L, Kraus PH, Valentin S, Saft C, Andrich J, Epplen JT. Arning L, et al. Among authors: epplen jt. Neurogenetics. 2005 Feb;6(1):25-8. doi: 10.1007/s10048-004-0198-8. Epub 2004 Nov 17. Neurogenetics. 2005. PMID: 15742215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page